Cargando…

Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China

Purpose: The dependence of patients with chronic diseases on drugs may affect their health-related quality of life (HRQoL). This study aims to assess the relationship between the direct economic burden caused by out-of-pocket (OOP) payments, drug accessibility, sociodemographic characteristics, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Shaoliang, Gong, Ying, Liu, Meixian, Yang, Duoer, Tang, Kean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006263/
https://www.ncbi.nlm.nih.gov/pubmed/33791272
http://dx.doi.org/10.3389/fpubh.2021.656104
_version_ 1783672278156836864
author Tang, Shaoliang
Gong, Ying
Liu, Meixian
Yang, Duoer
Tang, Kean
author_facet Tang, Shaoliang
Gong, Ying
Liu, Meixian
Yang, Duoer
Tang, Kean
author_sort Tang, Shaoliang
collection PubMed
description Purpose: The dependence of patients with chronic diseases on drugs may affect their health-related quality of life (HRQoL). This study aims to assess the relationship between the direct economic burden caused by out-of-pocket (OOP) payments, drug accessibility, sociodemographic characteristics, and health-related quality of life. Methods: 1,055 patients with chronic diseases from Gansu, Hebei, Sichuan, Zhejiang, and Tianjin were investigated. Data collection included basic conditions and economic and health insurance conditions of patients with chronic diseases. The CLAD and Tobit regression models were used to analyze and compare the health-related quality of life and influencing factors of patients with chronic diseases in five districts. Differentiated analysis was conducted through sub-sample regression to explore the variable health effects of patients with single and multiple diseases. Results: A total of 1,055 patients with chronic diseases participated in the study, 54.4% of whom were women. The overall average utility score was 0.727, of which Sichuan Province was the highest with 0.751. Participants reported the highest proportion of pain/discomfort problems, while patients reported the least problems with self-care. The improvement of drug accessibility and the reduction of the burden of out-of-pocket expenses have significant positive effects on HRQoL. Various sociodemographic factors such as age and gender also have significant impact on HRQoL of patients with chronic diseases. HRQoL of patients with multiple chronic diseases is more affected by various influencing factors than that of patients with single disease. Conclusion: In order to improve the quality of life of patients with chronic diseases, it is of great importance to ensure the accessibility of drugs and reduce patients' medication burden. Future focus should shift from preventing and controlling chronic diseases as individual diseases to meeting the comprehensive health needs of people suffering from multiple diseases.
format Online
Article
Text
id pubmed-8006263
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80062632021-03-30 Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China Tang, Shaoliang Gong, Ying Liu, Meixian Yang, Duoer Tang, Kean Front Public Health Public Health Purpose: The dependence of patients with chronic diseases on drugs may affect their health-related quality of life (HRQoL). This study aims to assess the relationship between the direct economic burden caused by out-of-pocket (OOP) payments, drug accessibility, sociodemographic characteristics, and health-related quality of life. Methods: 1,055 patients with chronic diseases from Gansu, Hebei, Sichuan, Zhejiang, and Tianjin were investigated. Data collection included basic conditions and economic and health insurance conditions of patients with chronic diseases. The CLAD and Tobit regression models were used to analyze and compare the health-related quality of life and influencing factors of patients with chronic diseases in five districts. Differentiated analysis was conducted through sub-sample regression to explore the variable health effects of patients with single and multiple diseases. Results: A total of 1,055 patients with chronic diseases participated in the study, 54.4% of whom were women. The overall average utility score was 0.727, of which Sichuan Province was the highest with 0.751. Participants reported the highest proportion of pain/discomfort problems, while patients reported the least problems with self-care. The improvement of drug accessibility and the reduction of the burden of out-of-pocket expenses have significant positive effects on HRQoL. Various sociodemographic factors such as age and gender also have significant impact on HRQoL of patients with chronic diseases. HRQoL of patients with multiple chronic diseases is more affected by various influencing factors than that of patients with single disease. Conclusion: In order to improve the quality of life of patients with chronic diseases, it is of great importance to ensure the accessibility of drugs and reduce patients' medication burden. Future focus should shift from preventing and controlling chronic diseases as individual diseases to meeting the comprehensive health needs of people suffering from multiple diseases. Frontiers Media S.A. 2021-03-12 /pmc/articles/PMC8006263/ /pubmed/33791272 http://dx.doi.org/10.3389/fpubh.2021.656104 Text en Copyright © 2021 Tang, Gong, Liu, Yang and Tang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Tang, Shaoliang
Gong, Ying
Liu, Meixian
Yang, Duoer
Tang, Kean
Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China
title Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China
title_full Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China
title_fullStr Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China
title_full_unstemmed Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China
title_short Do Drug Accessibility and OOP Burden Affect Health-Related Quality of Life of Patients With Chronic Diseases? — EQ-5D-5L Evaluation Evidence From Five Districts in China
title_sort do drug accessibility and oop burden affect health-related quality of life of patients with chronic diseases? — eq-5d-5l evaluation evidence from five districts in china
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006263/
https://www.ncbi.nlm.nih.gov/pubmed/33791272
http://dx.doi.org/10.3389/fpubh.2021.656104
work_keys_str_mv AT tangshaoliang dodrugaccessibilityandoopburdenaffecthealthrelatedqualityoflifeofpatientswithchronicdiseaseseq5d5levaluationevidencefromfivedistrictsinchina
AT gongying dodrugaccessibilityandoopburdenaffecthealthrelatedqualityoflifeofpatientswithchronicdiseaseseq5d5levaluationevidencefromfivedistrictsinchina
AT liumeixian dodrugaccessibilityandoopburdenaffecthealthrelatedqualityoflifeofpatientswithchronicdiseaseseq5d5levaluationevidencefromfivedistrictsinchina
AT yangduoer dodrugaccessibilityandoopburdenaffecthealthrelatedqualityoflifeofpatientswithchronicdiseaseseq5d5levaluationevidencefromfivedistrictsinchina
AT tangkean dodrugaccessibilityandoopburdenaffecthealthrelatedqualityoflifeofpatientswithchronicdiseaseseq5d5levaluationevidencefromfivedistrictsinchina